scholarly journals Risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis

2020 ◽  
pp. 205336912093402
Author(s):  
Jo Marsden ◽  
Hugo Pedder ◽  
Richard Santen ◽  
Keyword(s):  
Breast Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Cancer Diagnosis ◽  
Hormone Replacement ◽  
Breast Cancer Diagnosis ◽  
Risks And Benefits ◽  
Before And After

Use of Hormone Replacement Therapy (HRT) and Survival Following Breast Cancer Diagnosis

2005 ◽  
Vol 60 (10) ◽  
pp. 650-651 ◽  
Author(s):  
A S. Fletcher ◽  
B Erbas ◽  
Am M. Kavanaugh ◽  
S Hart ◽  
A Rodger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Cancer Diagnosis ◽  
Hormone Replacement ◽  
Breast Cancer Diagnosis

Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis

The Breast ◽  
2005 ◽  
Vol 14 (3) ◽  
pp. 192-200 ◽  
Author(s):  
A.S. Fletcher ◽  
B. Erbas ◽  
A.M. Kavanagh ◽  
S. Hart ◽  
A. Rodger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Cancer Diagnosis ◽  
Hormone Replacement ◽  
Breast Cancer Diagnosis

scholarly journals British Menopause Society consensus statement: The risks and benefits of HRT before and after a breast cancer diagnosis

2019 ◽  
Vol 25 (1) ◽  
pp. 33-37 ◽  
Author(s):  
Jo Marsden ◽  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Cancer Diagnosis ◽  
Hormone Replacement ◽  
Breast Cancer Diagnosis ◽  
Lifestyle Changes ◽  
Short Term Exposure ◽  
Increased Risk

In women at population risk of breast cancer (i.e. most), short-term exposure to hormone replacement therapy (i.e. up to five years’ use) for symptom relief exceeds its potential harms, including the associated, increased risk of breast cancer diagnosis. Many women and health care professionals, however, consider this to be unacceptably high, although the degree of risk conferred appears equivalent to, or less than that of, other lifestyle risk factors for this condition. In contrast, it is recommended that symptomatic women at high baseline risk due to a family history or a biopsy-confirmed high-risk benign breast condition and those with previous breast cancer should be managed initially with lifestyle changes and non-hormonal alternatives. In a minority, whose symptoms are refractory, hormone replacement therapy and or topical estrogen can be considered but prescription should only take place after a discussion between the patient, her primary health care and breast specialist teams.

Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival

2006 ◽  
Vol 119 (12) ◽  
pp. 2907-2915 ◽  
Author(s):  
Chantal Mascarenhas ◽  
Mats Lambe ◽  
Rino Bellocco ◽  
Kjell Bergfeldt ◽  
Tomas Riman ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Cancer Diagnosis ◽  
Cancer Survival ◽  
Hormone Replacement ◽  
Before And After ◽  
Ovarian Cancer Survival
Sign in / Sign up

Export Citation Format

Share Document